BRIEF published on 04/08/2026 at 23:59, 1 month ago ABIONYX publie des informations détaillées sur son capital social et ses droits de vote Euronext Paris Capital Social Droit De Vote Divulgation Financière ABIONYX
BRIEF published on 04/08/2026 at 23:59, 1 month ago ABIONYX Reports Share Capital and Voting Rights Details Euronext Paris Share Capital Voting Rights Financial Disclosure ABIONYX
PRESS RELEASE published on 04/08/2026 at 23:54, 1 month ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique sur le nombre total de droits de vote et d'actions en circulation, illustrant son engagement envers le développement de biomédicaments innovants pour les maladies inflammatoires les plus sévères Développement Maladies Inflammatoires Biopharma ABIONYX Pharma Biomédicaments
PRESS RELEASE published on 04/08/2026 at 23:54, 1 month ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares for March 31, 2026, in accordance with French regulations Shares French Regulations Total Voting Rights Biotech Company ABIONYX Pharma
BRIEF published on 03/17/2026 at 19:31, 1 month 22 days ago Mise à disposition du Document d’Enregistrement Universel 2025 par ABIONYX Pharma AMF Biopharmaceutique Document D’enregistrement ABIONYX Pharma Sepsis
BRIEF published on 03/17/2026 at 19:31, 1 month 22 days ago ABIONYX Pharma makes available the 2025 Universal Registration Document AMF Biopharmaceutical Registration Document ABIONYX Pharma Sepsis
PRESS RELEASE published on 03/17/2026 at 19:26, 1 month 22 days ago Inside Information / Other news releases ABIONYX Pharma announces the availability of its Universal Registration Document for the year 2025, filed with the AMF and accessible on their website AMF Biopharmaceutical Universal Registration Document ABIONYX Pharma Sepsis
PRESS RELEASE published on 03/17/2026 at 19:26, 1 month 22 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce la mise à disposition de son Document d'Enregistrement Universel 2025 auprès de l'AMF et en ligne AMF Document D'Enregistrement Universel Biothérapies ABIONYX Pharma Sepsis
BRIEF published on 03/03/2026 at 19:40, 2 months 5 days ago ABIONYX Announces February Voting Rights Update Euronext Paris Voting Rights AMF Regulations ABIONYX Pharma February 2026
BRIEF published on 03/03/2026 at 19:40, 2 months 5 days ago ABIONYX annonce une mise à jour de février concernant les droits de vote Euronext Paris Droit De Vote Réglementation AMF ABIONYX Pharma Février 2026
Published on 05/09/2026 at 01:30, 15 hours 58 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 17 hours 28 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 20 hours 50 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 22 hours 15 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 22 hours 26 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 22 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 22 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 22 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 22 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 22 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
